mhurhangee/ep-ind-claims huggingface dataset:
Method for operating a mobile station in a mobile radio system, wherein the mobile station has a connection to a network via a first base station, wherein the first base station sends a handover request (301, 402, 501) to the mobile station, wherein the first base station of the mobile radio system stops a data transmission via the radio interface to the mobile station following confirmation (302, 403, 502) of the handover request (301, 402, 501) by the mobile station, but leaves the data that are relevant to the connection stored until the expiration of a clock and also does not reallocate the resources that are necessary for maintaining the connection to the mobile station until the expiration of the clock, wherein the mobile station, following the handover request (301, 402, 501) by the first base station, tries to perform a handover to another base station as a test, confirms this handover request (301, 402, 501) and, if it does not already know, for example by measurement of a field strength of the other base station, the new base station with which it wishes to register again, seeks (303, 404, 503) a new base station, synchronizes (303, 404, 503) to this new base station, registers therewith and activates the radio link to the new base station.
A magnetic resonance imaging apparatus comprising: a sound input unit; a sound output unit configured to output a sound acquired by the sound input unit; a controller configured to compare the acquired sound to a sound generated by a pulse sequence corresponding to a driving pattern of a gradient coil unit, characterised in that the controller is further configured to increase an output level of the sound output unit when the acquired sound is not identical to the sound generated by the pulse sequence; and a sequence sound database configured to store patterns of sounds that are respectively generated for a plurality of pulse sequences registered in the MRI apparatus when a subject is scanned according to at least one of the pulse sequences. a sound input unit; a sound output unit configured to output a sound acquired by the sound input unit; a controller configured to compare the acquired sound to a sound generated by a pulse sequence corresponding to a driving pattern of a gradient coil unit, characterised in that the controller is further configured to increase an output level of the sound output unit when the acquired sound is not identical to the sound generated by the pulse sequence; and a sequence sound database configured to store patterns of sounds that are respectively generated for a plurality of pulse sequences registered in the MRI apparatus when a subject is scanned according to at least one of the pulse sequences.
A system for handling containers suitable for containing a medicinal substance, comprising - a wheel movable in rotation about an axis, - container handling clamps, the clamps being hinged to the wheel and being movable between a closed configuration for gripping a container and an open configuration for releasing a container, each pair of clamps comprising ramps suitable for lifting or depositing a container as the clamps move from one configuration to another, - stations, the clamps being suitable for depositing a container on the stations and for lifting a container from the stations; characterised in that the stations comprise a groove in which the ramps of a clamp are suitable for moving between the open and closed configurations. - a wheel movable in rotation about an axis, - container handling clamps, the clamps being hinged to the wheel and being movable between a closed configuration for gripping a container and an open configuration for releasing a container, each pair of clamps comprising ramps suitable for lifting or depositing a container as the clamps move from one configuration to another, - stations, the clamps being suitable for depositing a container on the stations and for lifting a container from the stations;
A method of forming passages of an integral manifold adjacent a cell stack of a flowing electrolyte battery, the method comprising: forming a mould cavity adjacent the cell stack, wherein the mould cavity is open to capillary openings of cells of the cell stack; inserting a manifold plug that defines a manifold cavity into the mould cavity; locating a plurality of pins in the mould cavity, wherein end regions of the pins are contiguous with the capillary openings and the pins pass through the manifold plug; filling the mould cavity with material; allowing the material to solidify into a moulded section; removing the pins from the moulded section and from the manifold plug; and removing the manifold plug from the moulded section; whereby passages are formed in the moulded section adjacent the manifold cavity, which passages are in fluid communication with both the capillary openings and the manifold cavity. forming a mould cavity adjacent the cell stack, wherein the mould cavity is open to capillary openings of cells of the cell stack; inserting a manifold plug that defines a manifold cavity into the mould cavity; locating a plurality of pins in the mould cavity, wherein end regions of the pins are contiguous with the capillary openings and the pins pass through the manifold plug; filling the mould cavity with material; allowing the material to solidify into a moulded section; removing the pins from the moulded section and from the manifold plug; and removing the manifold plug from the moulded section; whereby passages are formed in the moulded section adjacent the manifold cavity, which passages are in fluid communication with both the capillary openings and the manifold cavity.
An integrated circuit package, comprising a die; a thermal management aid mounted above the die; and an interface layer thermally coupling the die and the thermal management aid, characterized in that the interface layer further comprises an array of carbon nanotubes arranged in a plurality of individual bundles having their longitudinal axes aligned substantially perpendicular to a backside of the die.
A radio base station (1, 100) for designating, with respect to a mobile station (2, 200), a random access signal, and for receiving the designated random access signal from the mobile station, the radio base station comprising: a transmitter (1b, 160) configured to control transmission of downlink communication with the mobile station (2, 200); and a receiver (1a, 120) configured to control reception of uplink communication with the mobile station (2, 200); wherein the transmitter (1b, 160) is configured to allocate an individual preamble number to the mobile station (2, 200) and transmit the preamble number to the mobile station (2, 200) via a downlink data channel when the radio base station (1, 100) has user data to be transmitted to the mobile station (2, 200), the receiver (1a, 120) is configured to receive the random access signal including the preamble number transmitted from the mobile station (2, 200) via a random access channel, and the transmitter (1b, 160) is configured to transmit, to the mobile station, a random access response signal including timing adjustment information prepared based on a result of reception of the random access signal preamble for causing the mobile station (2, 200) to correct an uplink transmission timing with the timing adjustment information, and including allocation information about an uplink radio resource allocated to the mobile station (2, 200) to be used thereby to transmit control data. a transmitter (1b, 160) configured to control transmission of downlink communication with the mobile station (2, 200); and a receiver (1a, 120) configured to control reception of uplink communication with the mobile station (2, 200); wherein the transmitter (1b, 160) is configured to allocate an individual preamble number to the mobile station (2, 200) and transmit the preamble number to the mobile station (2, 200) via a downlink data channel when the radio base station (1, 100) has user data to be transmitted to the mobile station (2, 200), the receiver (1a, 120) is configured to receive the random access signal including the preamble number transmitted from the mobile station (2, 200) via a random access channel, and the transmitter (1b, 160) is configured to transmit, to the mobile station, a random access response signal including timing adjustment information prepared based on a result of reception of the random access signal preamble for causing the mobile station (2, 200) to correct an uplink transmission timing with the timing adjustment information, and including allocation information about an uplink radio resource allocated to the mobile station (2, 200) to be used thereby to transmit control data.
Composition for single-base propelling powder for ammunition, consisting of nitrocellulose as explosive base, an inert plasticizing component, at least one nitrocellulose stabilizing component and, optionally, a flash-reducer component and traces of one or more solvents and water, characterized in that said inert plasticizing component is constituted by dibutyl sebacate, wherein the dibutyl sebacate is present with a content comprised between 1% and 10% by weight.
A method of predicting a clinical outcome in a patient with glioma, the method comprising: assaying a serum sample from the patient for the presence of at least one miRNA selected from the group consisting of: Hsa-miR-20a-5p; comparing the amount of the at least one miRNA present in the serum sample with a reference value; wherein an increase in the amount of the at least one miRNA in the serum sample, such that the amount is more than twice the reference value, indicates a positive outcome in respect of the patient's glioma, wherein the reference value is the level of the same at least one miRNA present in a control subject without cancer. assaying a serum sample from the patient for the presence of at least one miRNA selected from the group consisting of: Hsa-miR-20a-5p; comparing the amount of the at least one miRNA present in the serum sample with a reference value; wherein an increase in the amount of the at least one miRNA in the serum sample, such that the amount is more than twice the reference value, indicates a positive outcome in respect of the patient's glioma, wherein the reference value is the level of the same at least one miRNA present in a control subject without cancer.
Apparatus for receiving an object in a vacuum coating installation, comprising a carrier which has a coating opening, comprising a holding device for holding the object in the coating opening, and comprising a pivot bearing for the holding device, which pivot bearing is secured to the carrier, has a pivot axis about which the holding device can be pivoted for turning the object that it holds in the coating opening, and has a bearing body (51, 51') with a circumferentially closed receptacle for a round body with an extent in the direction of the pivot axis, characterized in that the bearing body (51, 51') additionally has a circumferentially open receptacle for the round body, wherein the round body can be inserted into the circumferentially closed receptacle through the circumferentially open receptacle when the holding device is being arranged on the carrier. comprising a carrier which has a coating opening, comprising a holding device for holding the object in the coating opening, and comprising a pivot bearing for the holding device, which pivot bearing is secured to the carrier, has a pivot axis about which the holding device can be pivoted for turning the object that it holds in the coating opening, and has a bearing body (51, 51') with a circumferentially closed receptacle for a round body with an extent in the direction of the pivot axis, characterized in that the bearing body (51, 51') additionally has a circumferentially open receptacle for the round body, wherein the round body can be inserted into the circumferentially closed receptacle through the circumferentially open receptacle when the holding device is being arranged on the carrier.
Sea-island composite fiber having a cross section containing a plurality of island components having different island diameters, wherein at least one of the island components has island diameters of 10 to 1,000 nm with a diameter variation, calculated as standard deviation of island diameter/average island diameter, of 1.0 to 20.0% and wherein the variation in the island-to-island distance between centers of adjacent islands having the same diameter, calculated as standard deviation of island-to-island distance/average island-to-island distance, is 1.0 to 20.0%.
A pharmaceutical composition for use in the treatment of a human patient at risk of developing an acute exacerbation of COPD, comprising administering to the patient an effective dose or doses of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable salt, solvate or hydrate thereof over a period of not longer than seven days with at least one day between every dose, and repeating the administration to the patient of the effective dose or doses of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable salt, solvate or hydrate thereof after a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide treatment hiatus of at least 1 month from the start of the preceding administration.
Automotive electrical gas pump comprising: - a pump housing comprising a motor part, - an electronically commutated motor, wherein the motor comprises a motor stator with one single static electro-magnetic coil and a motor rotor, the motor stator driving the motor rotor rotating within a motor can, - an electronic circuit board for driving the electro-magnetic coll, and - a mounting frame being arranged in the motor part of the pump housing, being provided with a stator bed embedding at least in part the motor stator, and being provided with the motor can, wherein the mounting frame is made of plastic material comprising thermally high-conductive filler material, and wherein the mounting frame is in thermal contact with the electro-magnetic coil and with a magnet yoke of the motor stator. - a pump housing comprising a motor part, - an electronically commutated motor, wherein the motor comprises a motor stator with one single static electro-magnetic coil and a motor rotor, the motor stator driving the motor rotor rotating within a motor can, - an electronic circuit board for driving the electro-magnetic coll, and - a mounting frame being arranged in the motor part of the pump housing, being provided with a stator bed embedding at least in part the motor stator, and being provided with the motor can,
A downhole tool for use in a borehole having a surrounding wall, the tool comprising: a mandrel; at least one packing element disposed on the mandrel; a portion of the tool defining at least one first external port which in use is exposed to a borehole annulus between the tool and the surrounding wall; at least one piston housing disposed on the mandrel adjacent the at least one packing element and defining at least one second external port which in use is exposed to the borehole annulus between the tool and the surrounding wall, the at least one second external port communicable with the at least one first external port via at least one fluid path passing between the at least one packing element and the mandrel, the at least one piston housing being movable on the mandrel and compressing the at least one packing element; and at least one piston disposed in the at least one piston housing and being activatable from a first condition to a second condition, the at least one piston in the first condition allowing fluid communication via the at least one fluid path between the at least one first external port and the at least one second external port, the at least one piston in the second condition preventing fluid communication via the at least one fluid path between the at least one first external port and the at least one second external port. a mandrel; at least one packing element disposed on the mandrel; a portion of the tool defining at least one first external port which in use is exposed to a borehole annulus between the tool and the surrounding wall; at least one piston housing disposed on the mandrel adjacent the at least one packing element and defining at least one second external port which in use is exposed to the borehole annulus between the tool and the surrounding wall, the at least one second external port communicable with the at least one first external port via at least one fluid path passing between the at least one packing element and the mandrel, the at least one piston housing being movable on the mandrel and compressing the at least one packing element; and at least one piston disposed in the at least one piston housing and being activatable from a first condition to a second condition, the at least one piston in the first condition allowing fluid communication via the at least one fluid path between the at least one first external port and the at least one second external port, the at least one piston in the second condition preventing fluid communication via the at least one fluid path between the at least one first external port and the at least one second external port.
An in vitro method of predicting a human subject's likely response to an antipsychotic medication, said medication being selected from risperidone, quetiapine, perphenazine, or ziprasidone, the method comprising: obtaining a test haplotype for the subject by determining the genotype for at least one test marker in the CALN1 gene selected from the group consisting of: rs735368, rs749585, rs7790530, rs12699099, rs917209, rs1003685, rs917210, rs10255136, rs1232514, rs1232515, rs573092, rs10229537, and a marker that is between the delimiting markers rs2270209 to rs6961002 and that is in linkage disequilibrium with a marker selected from the group consisting of rs735368, rs749585, rs7790530, rs12699099, rs917209, rs1003685, rs917210, rs10255136, rs1232514, rs1232515, rs573092, and rs10229537, wherein the test haplotype indicates the subject's likely response to treatment with risperidone, quetiapine, perphenazine, or ziprasidone. obtaining a test haplotype for the subject by determining the genotype for at least one test marker in the CALN1 gene selected from the group consisting of: rs735368, rs749585, rs7790530, rs12699099, rs917209, rs1003685, rs917210, rs10255136, rs1232514, rs1232515, rs573092, rs10229537, and a marker that is between the delimiting markers rs2270209 to rs6961002 and that is in linkage disequilibrium with a marker selected from the group consisting of rs735368, rs749585, rs7790530, rs12699099, rs917209, rs1003685, rs917210, rs10255136, rs1232514, rs1232515, rs573092, and rs10229537, wherein the test haplotype indicates the subject's likely response to treatment with risperidone, quetiapine, perphenazine, or ziprasidone.
A light indicator for use in evaluating melanopsin active radiation of light, the light indicator comprising a first light indicator element comprising a first light reflective element and a second light indicator element comprising a second light reflective element, the light reflecting elements (112,122) having different wavelength dependencies of the spectral reflectivity, wherein the light reflecting elements (112,122) are selected to provide the same intensity ratio of reflected light of two or more different types of light irradiating on the light indicator elements (110,120), wherein the two or more different types of light have different spectral power distributions in the visible wavelength range but have the same ratios of the melanopic flux to the luminous flux, wherein the ratio of the melanopic flux to the luminous flux of light is defined as MEF = 1.22 ∑ λ = 380 780 SPD λ m λ Δλ ∑ λ = 380 780 SPD λ V λ Δλ wherein SPD(λ) is the spectral power distribution of the light, m(λ) is the melanopic sensitivity function, and V(λ) is the photopic sensitivity, and wherein the light reflecting elements (112,122) are further selected to provide a different intensity ratio of reflected light of two or more different types of light irradiating on the light indicator elements (110,120), wherein the two or more different types of light have different ratios of the melanopic flux to the luminous flux.
A method of forming a sealing land comprising: providing a single piece of abradable material, and characterized by then machining a mount structure and an open cell structure into the single piece of abradable material. providing a single piece of abradable material, and characterized by then machining a mount structure and an open cell structure into the single piece of abradable material.
A corneal implant comprising: a reversibly deformable scaffold (400; 410; 420; 430) having a three-dimensional structure characterised in that the three-dimensional structure includes discrete elements and forming a truncate dome (402; 412; 422; 424) defining a peripheral shape with mostly empty interior volume therein, wherein the scaffold has a rigidity greater than the cornea and the truncate dome is selected to provide a vision correction, wherein insertion of the scaffold into a corneal pocket results in a change in shape of the cornea or provides increased structural strength, wherein said discrete elements of said truncate dome comprise at least two rings, an upper ring and a lower ring, the upper ring forming a top of the truncate dome, and the bottom ring forming a bottom of the truncate dome.
A method of preparing a steviol glycoside composition, the method comprising: preparing a reaction mixture comprising: (a) rebaudioside W having the structure: and (b) a beta-glucosidase; and incubating the reaction mixture for a sufficient time to produce a steviol glycoside composition comprising rebaudioside WB1, rebaudioside WB2, or a combination thereof, wherein rebaudioside WB1 has the structure: and rebaudioside WB2 has the structure: preparing a reaction mixture comprising: (a) rebaudioside W having the structure: and (b) a beta-glucosidase; and (a) rebaudioside W having the structure: and (b) a beta-glucosidase; and incubating the reaction mixture for a sufficient time to produce a steviol glycoside composition comprising rebaudioside WB1, rebaudioside WB2, or a combination thereof, wherein rebaudioside WB1 has the structure: and rebaudioside WB2 has the structure: